First Long Island Investors’s Vertex Pharmaceuticals VRTX Stock Holding History

First Long Island Investors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-903	Closed	-$261K	–	61
2022 Q3	$261K	Hold	903	–	–	0.03%	54
2022 Q2	$254K	Sell	903 -16	-2%	-$4.28K	0.03%	52
2022 Q1	$240K	Sell	919 -88	-9%	-$20.9K	0.02%	55
2021 Q4	$221K	Buy	+1,007	New	+$196K	0.02%	63
2021 Q3	–	Sell	-1,163	Closed	-$234K	–	66
2021 Q2	$234K	Hold	1,163	–	–	0.02%	62
2021 Q1	$250K	Hold	1,163	–	–	0.02%	57
2020 Q4	$275K	Hold	1,163	–	–	0.03%	54
2020 Q3	$316K	Hold	1,163	–	–	0.03%	51
2020 Q2	$338K	Sell	1,163 -67	-5%	-$18.2K	0.04%	50
2020 Q1	$293K	Hold	1,230	–	–	0.04%	55
2019 Q4	$269K	Hold	1,230	–	–	0.03%	63
2019 Q3	$208K	Hold	1,230	–	–	0.03%	70
2019 Q2	$226K	Hold	1,230	–	–	0.03%	70
2019 Q1	$226K	Hold	1,230	–	–	0.03%	67
2018 Q4	$204K	Hold	1,230	–	–	0.03%	73
2018 Q3	$237K	Hold	1,230	–	–	0.03%	73
2018 Q2	$209K	Hold	1,230	–	–	0.03%	75
2018 Q1	$200K	Buy	+1,230	New	+$201K	0.03%	79

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

First Long Island Investors's VRTX Position: Q4 2022 in Review

First Long Island Investors sold out of Vertex Pharmaceuticals (VRTX) in Q4 2022, closing a stake of 903 shares — an estimated $261K sold.

First Long Island Investors first reported a position in VRTX in Q1 2018 and held it in 18 quarters. The position peaked at $338K in Q2 2020. 1,222 funds tracked by Wall St. Rank hold VRTX as of Q4 2022.

First Long Island Investors reported no remaining Vertex Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
First Long Island Investors sold 903 Vertex Pharmaceuticals shares in Q4 2022, an estimated $261K.
First Long Island Investors first reported a position in Vertex Pharmaceuticals in Q1 2018 and held it in 18 quarters.
First Long Island Investors's Vertex Pharmaceuticals position peaked at $338K in Q2 2020.
1,222 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2022.

Based on First Long Island Investors's 13F filing for Q4 2022, filed 14 Feb 2023.